-
公开(公告)号:US20060188495A1
公开(公告)日:2006-08-24
申请号:US11332194
申请日:2006-01-12
申请人: Hal Barron , Andrew Chan , Daniel Combs , Wolfgang Dummer , Paul Fielder , Gwendolyn Fyfe
发明人: Hal Barron , Andrew Chan , Daniel Combs , Wolfgang Dummer , Paul Fielder , Gwendolyn Fyfe
IPC分类号: A61K39/395
CPC分类号: C07K16/2887 , A61K2039/505 , A61K2039/545 , C07K2317/24 , C07K2317/52
摘要: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies effective to deplete B cells in the patient.
摘要翻译: 本发明提供使用有效消耗患者B细胞的较低剂量抗CD20抗体治疗自身免疫性疾病的方法。
-
公开(公告)号:US20080095771A1
公开(公告)日:2008-04-24
申请号:US11929950
申请日:2007-10-30
申请人: Hal Barron , Andrew Chan , Daniel Combs , Wolfgang Dummer , Paul Fielder , Gwendolyn Fyfe
发明人: Hal Barron , Andrew Chan , Daniel Combs , Wolfgang Dummer , Paul Fielder , Gwendolyn Fyfe
IPC分类号: A61K39/395 , A61P37/06
CPC分类号: C07K16/2887 , A61K2039/505 , A61K2039/545 , C07K2317/24 , C07K2317/52
摘要: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies effective to deplete B cells in the patient.
摘要翻译: 本发明提供使用有效消耗患者B细胞的较低剂量抗CD20抗体治疗自身免疫性疾病的方法。
-
公开(公告)号:US20080299117A1
公开(公告)日:2008-12-04
申请号:US12125037
申请日:2008-05-21
申请人: Hal V. Barron , Andrew C. Chan , Daniel Combs , Wolfgang Dummer , Paul J. Fielder , Gwendolyn Fyfe
发明人: Hal V. Barron , Andrew C. Chan , Daniel Combs , Wolfgang Dummer , Paul J. Fielder , Gwendolyn Fyfe
IPC分类号: A61K39/395 , A61P37/02
CPC分类号: C07K16/2887 , A61K2039/505 , A61K2039/545 , C07K2317/24 , C07K2317/52
摘要: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg effective to deplete B cells in the patient.
摘要翻译: 本发明提供使用有效消耗患者B细胞的100mg至200mg的较低剂量抗CD20抗体治疗自身免疫性疾病的方法。
-
公开(公告)号:US6037504A
公开(公告)日:2000-03-14
申请号:US204903
申请日:1998-12-03
IPC分类号: B01J23/86 , B01J23/88 , B01J23/889 , C07B61/00 , C07C29/149 , C07C31/20 , C07C67/08 , C07C29/14
CPC分类号: C07C29/149 , B01J23/8892 , Y02P20/52
摘要: In a process for producing aliphatic .alpha.,.omega.-diols comprising 4 to 12 C atoms from aliphatic .alpha.,.omega.-dicarboxylic acids comprising 4 to 12 C atoms, an oligoester of average chain length n=3 to n=4.5 and with an acid number of 40 to 60 mg KOH/g reaction mixture is first formed from a diol and a dicarboxylic acid, which oligoester is thereafter catalytically hydrogenated in the liquid phase. Hydrogenation is carried out continuously at 180 to 250.degree. C. and at an H.sub.2 pressure of 100 to 400 bar, over a pelletised catalyst which is free from Zn oxide and which comprises pressed powders of Cu, Mn and Al oxides with a content of at least one oxide of metals of subgroup VI of the periodic table of the elements (Mendeleev). The amount of H.sub.2 is 20 to 100 times the amount required stoichiometrically.
摘要翻译: 在由4-12个碳原子的脂肪族α,ω-二羧酸组成的含有4-12个碳原子的脂肪族α,ω-二醇的制备方法中,平均链长n = 3〜n = 4.5,酸值为 40至60mg KOH / g反应混合物首先由二醇和二羧酸形成,然后将低聚酯在液相中催化氢化。 在180-250℃,在100-400巴的H 2压力下,在不含Zn氧化物的颗粒状催化剂上连续进行氢化,其包含Cu,Mn和Al氧化物的压制粉末,其含量为 元素周期表第VI族金属的最少一种金属(Mendeleev)。 H2的量为化学计量所需量的20-100倍。
-
公开(公告)号:US5300643A
公开(公告)日:1994-04-05
申请号:US935627
申请日:1992-08-25
申请人: Klaus Grohe , Wolfgang Dummer , Kai Rossen , Arnold Paessens
发明人: Klaus Grohe , Wolfgang Dummer , Kai Rossen , Arnold Paessens
IPC分类号: A61K31/47 , A61K31/535 , A61K31/54 , A61P31/12 , C07D215/56 , C07D401/04 , C07D401/10 , C07D401/14 , C07D413/04 , C07D417/04 , C07D471/04 , C07D498/04 , C07D513/04 , C07D519/00 , C07D413/10 , C07D417/10
CPC分类号: C07D401/04 , C07D215/56 , C07D401/10 , C07D401/14 , C07D471/04
摘要: New quinolone-carboxylic acids of the general formula (I) ##STR1## wherein the definitions for R.sub.1 -R.sub.9 are given in the description, a process for their preparation and their use as medicaments, in particular as antiviral agents.
摘要翻译: 通式(I)的新型喹诺酮 - 羧酸(I)其中R1-R9的定义在本说明书中给出,其制备方法及其作为药物的用途,特别是作为抗病毒剂。
-
6.
公开(公告)号:US5217972A
公开(公告)日:1993-06-08
申请号:US585580
申请日:1990-09-19
申请人: Klaus Grohe , Wolfgang Dummer , Kai Rossen , Arnold Paessens
发明人: Klaus Grohe , Wolfgang Dummer , Kai Rossen , Arnold Paessens
IPC分类号: A61K31/47 , A61K31/535 , A61K31/54 , A61P31/12 , C07D215/56 , C07D401/04 , C07D401/10 , C07D401/14 , C07D413/04 , C07D417/04 , C07D471/04 , C07D498/04 , C07D513/04 , C07D519/00
CPC分类号: C07D401/04 , C07D215/56 , C07D401/10 , C07D401/14 , C07D471/04
摘要: New quinolone-carboxylic acids of the general formula (I) ##STR1## wherein the definitions for R.sub.1 -R.sub.9 are given in the description, a process for their preparation and their use as medicaments, in particular as antiviral agents.
摘要翻译: 通式(I)的新型喹诺酮 - 羧酸(I)其中R1-R9的定义在本说明书中给出,其制备方法及其作为药物的用途,特别是作为抗病毒剂。
-
-
-
-
-